Lavipharm

Lavipharm Book Value per Share

The Book Value per Share of Lavipharm (LAVI.AT) as of Oct 17, 2026 is 0.33 EUR. In the previous year, Book Value per Share was 0.31 EUR — a change of 6.50% (higher).

Book Value per Share

0.33EUR

YoY

6.50%

Last updated:

Book Value per Share of Lavipharm is 2025 0.33 EUR. Book Value per Share of Lavipharm was 2024 0.31 EUR. It decreases by 6.50% higher compared to the previous year.

The Lavipharm Book Value per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Book Value per Share
Date
Book Value per Share
Jan 1, 2018
-0.12 EUR
Jan 1, 2019
-0.09 EUR
Jan 1, 2020
-0.07 EUR
Jan 1, 2021
-0.06 EUR
Jan 1, 2022
0.24 EUR
Jan 1, 2023
0.25 EUR
Jan 1, 2024
0.31 EUR
Jan 1, 2025
0.33 EUR
The Lavipharm Book Value per Share history
YEARBook Value per ShareYoY
0.33EUR+6.50%
0.31EUR+23.96%
0.25EUR+6.11%
0.24EUR-503.75%
-0.06EUR-18.91%
-0.07EUR-14.57%
-0.09EUR-26.25%
-0.12EUR-1.96%
-0.12EUR-37.41%
-0.19EUR-11.22%
-0.21EUR+54.05%
-0.14EUR—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Lavipharm Stock analysis

What does Lavipharm do? Lavipharm SA is a pharmaceutical company based in Athens, Greece, operating within the Health Care sector. The company, listed on the Vienna Stock Exchange under ticker LAVI.AT, has an ISIN code of GRS246003008. Lavipharm SA was founded through an IPO on November 8, 1995, and currently employs 184 full-time staff. The company engages in the manufacture and import of pharmaceuticals and veterinary products. Its product portfolio includes pharmaceuticals for anti-inflammatory, asthma, neurological, antiseptic, analgesic, dermatological, and gastrointestinal treatments. Additionally, Lavipharm SA offers cosmetic products under the brand names Castalia Soins Dermocosmetiques and Laviderm Active Technology, targeting skin, face, body, scalp, and hair care. The company also distributes over-the-counter (OTC) products such as cold and flu remedies, oral care items, dermatological products, condoms, antiseptics, analgesics, laxatives, and gynecological products. Lavipharm SA is the parent company of the Lavipharm Group of Companies. In January 2014, Robertet SA, alongside CODIF, acquired HITEX, a company specializing in carbon dioxide extraction subcontracting, from Lavipharm SA. The company maintains a website at https://www.lavipharm.com/. Lavipharm is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Lavipharm stock

Book Value per Share of Lavipharm is 0.33 EUR in 2025.

Book Value per Share of Lavipharm changed from 0.31 EUR to 0.33 EUR, representing a 6.50% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Book Value per Share Lavipharm since 2006 – with annual values, charts, and detailed analysis.

Book value per share represents the net asset value of the company per outstanding share. Comparing it to the stock price helps assess whether a stock is undervalued.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — Lavipharm

All Key Metrics — Lavipharm